Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX1 | P51575 | 9/20 | 0.77 |
| ▸ | TMPRSS4 | Q9NRS4 | 8/20 | 0.71 |
| ▸ | P2RX4 | Q99571 | 4/20 | 0.70 |
| ▸ | P2RX7 | Q99572 | 4/20 | 0.70 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.68 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.68 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.68 |
| ▸ | KCNMA1 | Q12791 | 2/20 | 0.64 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.61 |
| ▸ | EGFR | P00533 | 1/20 | 0.61 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.61 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.61 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.61 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30771736 | 0.88 | P2RX1 (0.74) | P2RX1TMPRSS4P2RX4P2RX7KCNMA1 | |
| SCHEMBL18341118 | 0.88 | P2RX1 (0.74) | P2RX1TMPRSS4P2RX4P2RX7KCNMA1 | |
| SCHEMBL18290067 | 0.88 | PNLIP (0.67) | P2RX1TMPRSS4P2RX4P2RX7PTGS1 | |
| SCHEMBL29454776 | 0.87 | P2RX1 (1.00) | P2RX1TMPRSS4P2RX4P2RX7KCNMA1 | |
| SCHEMBL2169619 | 0.87 | P2RX1 (1.00) | P2RX1TMPRSS4P2RX4P2RX7KCNMA1 | |
| SCHEMBL23675396 | 0.87 | P2RX1 (0.70) | P2RX1TMPRSS4P2RX4P2RX7KCNMA1 | |
| SCHEMBL30100500 | 0.87 | P2RX1 (0.70) | P2RX1TMPRSS4P2RX4P2RX7KCNMA1 | |
| SCHEMBL20413313 | 0.87 | P2RX1 (0.70) | P2RX1TMPRSS4P2RX4P2RX7KCNMA1 | |
| SCHEMBL14886091 | 0.86 | P2RX1 (0.77) | P2RX1TMPRSS4P2RX4P2RX7KCNMA1 | |
| SCHEMBL28916380 | 0.85 | P2RX1 (0.68) | P2RX1TMPRSS4P2RX4P2RX7KCNMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3263145-B1 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR LOCKING CATHETERS | BECTON DICKINSON CO (US) | 2021-01-20 | — | — | EP | claimed |
| US-20200038350-A1 | CHEMICAL MODULATORS OF SIGNALING PATHWAYS AND THERAPEUTIC USE | DUKE UNIVERSITY | 2020-02-06 | — | — | US | claimed |
| EP-3313388-A1 | CHEMICAL MODULATORS OF SIGNALING PATHWAYS AND THERAPEUTIC USE | Duke University (US) | 2018-05-02 | — | — | EP | claimed |
| US-9872941-B2 | Antimicrobial compositions and methods for locking catheters | BECTON, DICKINSON AND COMPANY (US) | 2018-01-23 | — | — | US | claimed |
| EP-3263145-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR LOCKING CATHETERS | Becton, Dickinson and Company (US) | 2018-01-03 | — | — | EP | claimed |
| EP-1998825-B1 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR LOCKING CATHETERS | BECTON DICKINSON CO (US) | 2017-10-18 | — | — | EP | claimed |
| US-20170216493-A1 | Antimicrobial Compositions and Methods for Locking Catheters | BECTON, DICKINSON AND COMPANY | 2017-08-03 | — | — | US | claimed |
| US-9649411-B2 | Antimicrobial compositions and methods for locking catheters | BECTON, DICKINSON AND COMPANY (US) | 2017-05-16 | — | — | US | claimed |
| WO-2016210289-A1 | CHEMICAL MODULATORS OF SIGNALING PATHWAYS AND THERAPEUTIC USE | DUKE UNIVERSITY (US) | 2016-12-29 | — | — | WO | claimed |
| US-20160213818-A1 | Antimicrobial Compositions and Methods for Locking Catheters | BECTON, DICKINSON AND COMPANY | 2016-07-28 | — | — | US | claimed |
| WO-2007100776-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR LOCKING CATHETERS | BECTON, DICKINSON AND COMPANY (US) | 2007-09-07 | — | — | WO | claimed |
| US-20070202177-A1 | Antimicrobial Compositions and Methods for Locking Catheters | BECTON, DICKINSON AND COMPANY (US) | 2007-08-30 | — | — | US | claimed |
| EP-1071324-B1 | BLOOMING TYPE GERMICIDAL HARD-SURFACE CLEANERS | RECKITT BENCKISER INC (US) | 2004-02-11 | — | — | EP | claimed |
| US-6395697-B1 | IN SOLVENT AND WATER SOLUTION | RECKITT BENCKISER INC. | 2002-05-28 | — | — | US | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| EP-1071324-A1 | BLOOMING TYPE GERMICIDAL HARD-SURFACE CLEANERS | Reckitt Benckiser Inc. (US) | 2001-01-31 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-6066606-A | MIXTURE OF TERPENE, SURFACTANT AND WATER | RECKITT & COLMAN INC. (US) | 2000-05-23 | — | — | US | claimed |
| WO-1999052361-A1 | BLOOMING TYPE GERMICIDAL HARD-SURFACE CLEANERS | RECKITT BENCKISER INC. (US) | 1999-10-21 | — | — | WO | claimed |
| US-4326977-A | Liquid antiseptic cleaners with improved foaming properties | BASF WYANDOTTE CORPORATION (US) | 1982-04-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200038350-A1 | CHEMICAL MODULATORS OF SIGNALING PATHWAYS AND THERAPEUTIC USE | SFRP1, FZD7, WNT1 | P2RX1 3423/4885TMPRSS4 2074/4885P2RX4 3784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.